UnitedHealth Group Ownership
| UNH Stock | USD 518.20 4.77 0.93% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 930 M | Current Value 927 M | Avarage Shares Outstanding 1.1 B | Quarterly Volatility 288.9 M |
UnitedHealth |
UnitedHealth Stock Ownership Analysis
About 90.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.44. UnitedHealth Group recorded earning per share (EPS) of 15.49. The entity last dividend was issued on the 10th of March 2025. The firm had 2:1 split on the 31st of May 2005. UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. Unitedhealth operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 350000 people. For more information please call Andrew Witty at (800)-328-5979 or visit https://www.unitedhealthgroup.com.Besides selling stocks to institutional investors, UnitedHealth Group also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different UnitedHealth Group's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align UnitedHealth Group's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
UnitedHealth Group Quarterly Liabilities And Stockholders Equity |
|
UnitedHealth Group Insider Trades History
Less than 1% of UnitedHealth Group Incorporated are currently held by insiders. Unlike UnitedHealth Group's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against UnitedHealth Group's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of UnitedHealth Group's insider trades
UnitedHealth Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as UnitedHealth Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading UnitedHealth Group Incorporated backward and forwards among themselves. UnitedHealth Group's institutional investor refers to the entity that pools money to purchase UnitedHealth Group's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Capital Research & Mgmt Co - Division 3 | 2024-12-31 | 15.6 M | Norges Bank | 2024-12-31 | 12.6 M | Northern Trust Corp | 2024-12-31 | 9.5 M | Franklin Resources Inc | 2024-12-31 | 8.9 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 8.6 M | Royal Bank Of Canada | 2024-12-31 | 8.1 M | Bank Of New York Mellon Corp | 2024-12-31 | 7.9 M | Bank Of America Corp | 2024-12-31 | 7.8 M | Alliancebernstein L.p. | 2024-12-31 | 7.5 M | Vanguard Group Inc | 2024-12-31 | 85.1 M | Blackrock Inc | 2024-12-31 | 72 M |
UnitedHealth Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific UnitedHealth Group insiders, such as employees or executives, is commonly permitted as long as it does not rely on UnitedHealth Group's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases UnitedHealth Group insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Noel Timothy John over two months ago Insider Trading | ||
Cianfrocco Heather over six months ago Disposition of 10712 shares by Cianfrocco Heather of UnitedHealth Group at 327.64 subject to Rule 16b-3 | ||
Andrew Witty over a year ago Payment of 372 shares by Andrew Witty of UnitedHealth Group subject to Rule 16b-3 | ||
Andrew Witty over a year ago Acquisition by Andrew Witty of 100 shares of UnitedHealth Group subject to Rule 16b-3 |
UnitedHealth Group's latest congressional trading
Congressional trading in companies like UnitedHealth Group, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in UnitedHealth Group by those in governmental positions are based on the same information available to the general public.
| 2025-03-10 | Representative Jefferson Shreve | Acquired $15K to $50K | Verify | ||
| 2025-03-07 | Representative Gil Cisneros | Acquired $15K to $50K | Verify | ||
| 2025-02-14 | Representative Michael McCaul | Acquired $50K to $100K | Verify | ||
| 2025-02-12 | Representative Gil Cisneros | Acquired $15K to $50K | Verify | ||
| 2025-01-15 | Representative Rick Larsen | Acquired Under $15K | Verify | ||
| 2025-01-05 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2024-12-18 | Representative Michael McCaul | Acquired $50K to $100K | Verify | ||
| 2024-12-06 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-11-06 | Representative Earl Blumenauer | Acquired $15K to $50K | Verify | ||
| 2024-09-06 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-09-02 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-08-21 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $100K to $250K | Verify | ||
| 2023-10-13 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2023-10-11 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify | ||
| 2022-11-12 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2019-10-18 | Senator James Inhofe | Acquired $15K to $50K | Verify |
UnitedHealth Group Outstanding Bonds
UnitedHealth Group issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. UnitedHealth Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most UnitedHealth bonds can be classified according to their maturity, which is the date when UnitedHealth Group Incorporated has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| UNIT 105 15 FEB 28 Corp BondUS91327TAA97 | View | |
| UNITEDHEALTH GROUP INC Corp BondUS91324PAR38 | View | |
| UNITEDHEALTH GROUP INC Corp BondUS91324PCZ36 | View | |
| UNITEDHEALTH GROUP INC Corp BondUS91324PCY60 | View | |
| UNITEDHEALTH GROUP INC Corp BondUS91324PCX87 | View | |
| UNITEDHEALTH GROUP INC Corp BondUS91324PCW05 | View | |
| UNITEDHEALTH GROUP INC Corp BondUS91324PCV22 | View | |
| UNITEDHEALTH GROUP INC Corp BondUS91324PCR10 | View |
UnitedHealth Group Corporate Filings
F4 | 20th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 27th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F3 | 31st of January 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 16th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.026 | Dividend Share 8.18 | Earnings Share 15.49 | Revenue Per Share | Quarterly Revenue Growth 0.068 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.